Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.4350 (-4.26%) ($8.4350 - $8.4350) on Mon. Jan. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.81% (three month average) | RSI | 44 | Latest Price | $8.4350(-4.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting EDIT price | EDIT will decline at least -2.405% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.405% (StdDev 4.81%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-1.92(-122.76%) | Resistance Level | $8.88 | 5 Day Moving Average | $8.44(-0.06%) | 10 Day Moving Average | $8.66(-2.6%) | 20 Day Moving Average | $8.88(-5.01%) | To recent high | -36.2% | To recent low | 2.7% | Market Cap | $N/A | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |